SCHEMBL5506872

SCHEMBL5506872

Cc1ccc2c(N3CCC(N(C)C(=O)O)C3)nc(-c3c(O)cccc3F)nc2c1

nearest known ligand 0.68

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 4/20 0.68
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38
OGFRL1 Q5TC84 1/20 0.38
MAPT P10636 3/20 0.36
JAK2 O60674 7/20 0.34
JAK3 P52333 4/20 0.34
TSHR P16473 1/20 0.34
SETD2 Q9BYW2 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
PRKDC P78527 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4015698 1.00 CHEK2 (0.68) CHEK2OPRM1OPRD1OPRK1OGFRL1
SCHEMBL1623662 0.95 CHEK2 (0.61) CHEK2OPRM1OPRD1OPRK1OGFRL1
Hydrochloric Acid SCHEMBL4020400 0.94 CHEK2 (0.60) CHEK2OPRM1OPRD1OPRK1OGFRL1
SCHEMBL1623249 0.89 CHEK2 (0.62) CHEK2MAPTJAK2JAK3TSHR
SCHEMBL184161 0.88 CHEK2 (0.63) CHEK2MAPTJAK2JAK3
SCHEMBL184160 0.88 CHEK2 (0.63) CHEK2MAPTJAK2JAK3
SCHEMBL2733679 0.87 CHEK2 (0.57) CHEK2MAPTJAK2JAK3SETD2
SCHEMBL4011372 0.86 CHEK2 (0.67) CHEK2OPRM1OPRD1OPRK1OGFRL1
SCHEMBL4014738 0.86 CHEK2 (0.67) CHEK2OPRM1OPRD1OPRK1OGFRL1
SCHEMBL5512766 0.86 CHEK2 (0.67) CHEK2OPRM1OPRD1OPRK1OGFRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1784393-A1 QUINAZOLINES USEFUL AS MODULATORS OF ION CHANNELS Vertex Pharmaceuticals Incorporated (US) 2007-05-16 EP disclosed
WO-2006028904-A1 QUINAZOLINES USEFUL AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-03-16 WO disclosed